Lee Jun-Haeng, Kim Jae J
Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Irwon-dong, Gangnam-gu, Seoul 135-710, South Korea.
World J Gastroenterol. 2007 Jul 21;13(27):3657-61. doi: 10.3748/wjg.v13.i27.3657.
Endoscopic mucosal resection (EMR) has been established as one of the treatment options for early gastric cancer (EGC). However, there are many uncertain areas such as indications of EMR, best treatment methods, management of complications and follow-up methods after the procedure. Most studies on this topic have been carried out by researchers in Japan. In Korea, gastric cancer is the most common malignant disease, and the second leading cause of cancer death. In these days, EMR for EGC is widely performed in many centers in Korea. In this review, we will provide an overview of the techniques and outcomes of EMR in Korea.
内镜黏膜切除术(EMR)已被确立为早期胃癌(EGC)的治疗选择之一。然而,EMR存在许多不确定的方面,如EMR的适应证、最佳治疗方法、并发症的处理以及术后随访方法等。关于这一主题的大多数研究是由日本的研究人员进行的。在韩国,胃癌是最常见的恶性疾病,也是癌症死亡的第二大主要原因。目前,韩国许多中心都广泛开展了针对EGC的EMR。在本综述中,我们将概述韩国EMR的技术和治疗结果。